Related references
Note: Only part of the references are listed.Tumor Microenvironment Acidity Triggers Lipid Accumulation in Liver Cancer via SCD1 Activation
Ming Ding et al.
MOLECULAR CANCER RESEARCH (2022)
Therapeutic Implications of Tumor Microenvironment in Lung Cancer: Focus on Immune Checkpoint Blockade
Carlo Genova et al.
FRONTIERS IN IMMUNOLOGY (2022)
Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
Xiang Zhang et al.
GUT (2021)
Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients
Wenjie Wang et al.
BMC GASTROENTEROLOGY (2021)
Development of a lipid metabolism-related gene model to predict prognosis in patients with pancreatic cancer
Hong Xu et al.
WORLD JOURNAL OF CLINICAL CASES (2021)
Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans
Li Che et al.
GUT (2020)
SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC
Qingzhu Gao et al.
CELL DEATH AND DIFFERENTIATION (2020)
Disease Burden of Hepatocellular Carcinoma: A Global Perspective
Mehmet Sayiner et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Targeting Tumor Microenvironment for Cancer Therapy
Catarina Roma-Rodrigues et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
TMB is linked with prognosis
Diana Romero
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
The Tumor Microenvironment Innately Modulates Cancer Progression
Dominique C. Hinshaw et al.
CANCER RESEARCH (2019)
Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER plus luminal subtypes
Chitra Joseph et al.
BRITISH JOURNAL OF CANCER (2018)
A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL
Allison L. Cooke et al.
JOURNAL OF LIPID RESEARCH (2018)
The mediator complex in genomic and non-genomic signaling in cancer
Hannah Weber et al.
STEROIDS (2018)
Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma
Thitinee Vanichapol et al.
BIOMED RESEARCH INTERNATIONAL (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Facing up to the global challenges of ageing
Linda Partridge et al.
NATURE (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma A meta-analysis
Wei Ding et al.
MEDICINE (2018)
Both de novo synthetized and exogenous fatty acids support the growth of hepatocellular carcinoma cells
Dan Cao et al.
LIVER INTERNATIONAL (2017)
Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer
Stephen J. Luen et al.
PATHOLOGY (2017)
A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours
Matthew R. Russell et al.
BRITISH JOURNAL OF CANCER (2017)
Lipid metabolic reprogramming in cancer cells
S. Beloribi-Djefaflia et al.
ONCOGENESIS (2016)
New horizons in tumor microenvironment biology: challenges and opportunities
Fei Chen et al.
BMC MEDICINE (2015)
New immunotherapies targeting the PD-1 pathway
Jordan M. Chinai et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Expression and roles of fatty acid synthase in hepatocellular carcinoma
Qiwei Hao et al.
ONCOLOGY REPORTS (2014)
Cellular Fatty Acid Metabolism and Cancer
Erin Currie et al.
CELL METABOLISM (2013)
The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation
Sohail Malik et al.
NATURE REVIEWS GENETICS (2010)
Identification, structure, and functional requirement of the Mediator submodule Med7N/31
Tobias Koschubs et al.
EMBO JOURNAL (2009)
Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment
Alexander R. A. Anderson et al.
CELL (2006)
Share Paper
